| 发明名称 |
22012, human carboxypeptidase |
| 摘要 |
The present invention relates to a newly identified human carboxypeptidase. The invention also relates to polynucleotides encoding the carboxypeptidase. The invention further relates to methods using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders. The invention further relates to drug-screening methods using the carboxypeptidase polypeptides and polynucleotides to identify agonists and antagonists for diagnosis and treatment. The invention further encompasses agonists and antagonists based on the carboxypeptidase polypeptides and polynucleotides. The invention further relates to procedures for producing the carboxypeptidase polypeptides and polynucleotides.
|
| 申请公布号 |
US6369210(B1) |
申请公布日期 |
2002.04.09 |
| 申请号 |
US19990345469 |
申请日期 |
1999.06.30 |
| 申请人 |
MILLENNIUM PHARMACEUTICALS, INC. |
发明人 |
KAPELLER-LIBERMANN ROSANA;MACBETH KYLE J.;WILLIAMSON MARK |
| 分类号 |
G01N33/50;A61K38/00;A61K38/46;A61P1/00;A61P1/04;A61P1/12;A61P1/16;A61P3/00;A61P3/02;A61P3/10;A61P7/02;A61P7/04;A61P9/00;A61P9/02;A61P9/10;A61P9/12;A61P11/00;A61P15/06;A61P19/04;A61P25/00;A61P25/14;A61P25/16;A61P25/28;A61P29/00;A61P31/04;A61P31/18;A61P31/22;A61P33/00;A61P33/02;A61P35/00;A61P35/04;A61P37/02;A61P37/08;A61P39/02;A61P43/00;C07K16/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N9/48;C12N15/09;C12N15/57;C12Q1/37;C12Q1/68;G01N33/15;G01N33/53;G01N33/566;(IPC1-7):C07H21/04;C07H5/04;C07H19/00;C07H21/00 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
